Minimal regulation of platelet activity by PECAM-1

Tarvinder S Dhanjal1, Ewan A Ross, Jocelyn M Auger

  • 1Centre for Cardiovascular Sciences, Institute of Biomedical Research, Division of Medical Sciences, The Medical School, University of Birmingham, Birmingham B15 2TT, UK. t.s.dhanjal@bham.ac.uk

Platelets
|March 17, 2007
PubMed

Insights

Platelet activation by key receptors is minimally affected by Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1). This study questions PECAM-1's role as a major regulator of platelet function.

Area of Science:

  • Immunology
  • Hematology
  • Cellular Biology

Background:

  • Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1), an immunoglobulin superfamily member, is expressed on platelets.
  • Previous studies suggest PECAM-1 has contrasting effects on platelet activation pathways involving GPVI and alphaIIbbeta3 receptors.

Purpose of the Study:

  • To investigate the role of PECAM-1 in platelet activation mediated by collagen receptor GPVI, integrin alphaIIbbeta3, and lectin receptor CLEC-2.
  • To compare the inhibitory effect of PECAM-1 with prostacyclin (PGI2) and to assess its role in thrombus formation.

Main Methods:

  • Utilized PECAM-1 knockout-mice and cross-linking antibodies to study platelet responses.
  • Compared platelet activation and thrombus formation in PECAM-1 deficient platelets versus wild-type controls.

Main Results:

  • PECAM-1 exhibited a minor inhibitory role in platelet activation by GPVI, alphaIIbbeta3, CLEC-2, and thrombin.
  • The inhibitory effect of PECAM-1 was significantly less pronounced than that of PGI2.
  • No significant difference in collagen-induced thrombus formation was observed between PECAM-1 knockout and control platelets.

Conclusions:

  • PECAM-1 demonstrates a very mild or negligible effect on platelet activation by various agonists.
  • The findings question the physiological significance of PECAM-1 as a major regulator of platelet activation.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...